High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors

International Journal of Oncology

Volumn 36, Issue 2, 2010, Pages 301-306

  Righi, Valeria ^a   Andronesi, Ovidiu C ^a   Mintzopoulos, Dionyssios ^a   Black, Peter M ^b   Tzika, A Aria ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Brain CNS cancers; Ex vivo high resolution magic angle spinning magnetic resonance spectroscopy; Tumor biomarkers

Indexed keywords

GLYCINE; INOSITOL;

ADENOCARCINOMA; ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN METASTASIS; BRAIN SURGERY; BRAIN TUMOR; BREAST CANCER; DIAGNOSTIC IMAGING; EPILEPSY; GLIOBLASTOMA; HIGH RESOLUTION MAGIC ANGLE SPINNING PROTON NUCLEAR MAGNETIC RESONANCE; HUMAN; HUMAN TISSUE; MENINGIOMA; NEURILEMOMA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR BIOPSY;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; GLIOBLASTOMA; GLYCINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 75649125584     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000500     Document Type: Article

References (38)

1. Kinoshita Y and Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10: 2-12, 1997.
2. 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 24: 123-136, 1992.
3. 1H NMR spectroscopic investigation. NMR Biomed 18: 371-382, 2005.
4. Tzika AA, Astrakas L, Cao H, et al: Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med 20: 199-208, 2007.
5. 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. MAGMA 22: 33-41, 2009.
6. Betz H, Gomeza J, Armsen W, Scholze P and Eulenburg V: Glycine transporters: essential regulators of synaptic transmission. Biochem Soc Trans 34: 55-58, 2006.
7. Furuya S, Tabata T, Mitoma J, et al: L-serine and glycine serve as major astroglia-derived trophic factors for cerebellar Purkinje neurons. Proc Natl Acad Sci USA 97: 11528-11533, 2000.
8. Yang L, Tanaka J, Zhang B, Sakanaka M and Maeda N: Astrocytes modulate nitric oxide production by microglial cells through secretion of serine and glycine. Biochem Biophys Res Commun 251: 277-282, 1998.
9. Huisman TA, Thiel T, Steinmann B, Zeilinger G and Martin E: Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation. Eur Radiol 12: 858-861, 2002.
10. Viola A, Chabrol B, Nicoli F, Confort-Gouny S, Viout P and Cozzone PJ: Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia. Pediatr Res 52: 292-300, 2002.
11. Kinoshita Y, Kajiwara H, Yokota A and Koga Y: Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35: 604-613, 1994.
12. Waziri R: Glycine therapy of schizophrenia. Biol Psychiatry 23: 210-211, 1988.
13. Heresco-Levy U, Ermilov M, Lichtenberg P, Bar G and Javitt DC: High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatry 55: 165-171, 2004.
14. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Horowitz A and Kelly D: Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry 169: 610-617, 1996.
15. 1H-MRS study. Magn Reson Med 60: 782-789, 2008.
16. Fisher SK, Novak JE and Agranoff BW: Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J Neurochem 82: 736-754, 2002.
17. Schulte RF and Boesiger P: ProFit: two-dimensional priorknowledge fitting of J-resolved spectra. NMR Biomed 19: 255-263, 2006.
18. Prescot AP, De BFB, Wang L, et al: In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T. Magn Reson Med 55: 681-686, 2006.
19. 1H NMR measurement of glycine in rat brain at 9.4 T at short echo time. Magn Reson Med 60: 727-731, 2008.
20. Mader I, Roser W, Hagberg G, et al: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 4: 139-150, 1996.
21. Candiota A, Majos C, Julia-Sape M, et al: M-Inositol and glycine content mesurment for grading astrocytic tumours with in vivo MRS. Magn Reson Mater Phy 18: S193, 2005.
22. Galanaud D, Chinot O, Nicoli F, et al: Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 98: 269-276, 2003.
23. Hattingen E, Raab P, Franz K, Zanella FE, Lanfermann H and Pilatus U: Myo-inositol: a marker of reactive astrogliosis in glial tumors? NMR Biomed 21: 233-241, 2008.
24. Majos C, Julia-Sape M, Alonso J, et al: Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. AJNR Am J Neuroradiol 25: 1696-1704, 2004.
25. Ishimaru H, Morikawa M, Iwanaga S, Kaminogo M, Ochi M and Hayashi K: Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol 11: 1784-1791, 2001.
26. 1H brain tumor spectra: a multicenter study. Magn Reson Med 49: 29-36, 2003.
27. Meiboom S and Gill D: Modified spiin-echo method for measuring nuclear relaxation time. Rev Sci Instrum 29: 688-691, 1958.
28. Levenberg K: A method for the solution of certain non-linear problems in least squares. Q Appl Math 2: 164-168, 1944.
29. Marquardt D: An algorithm for least-aquares estimation of nonlinear parameters. SIAM Appl Math: 431-441, 1963.
30. 1H HR-MAS spectroscopy. Magn Reson Med 55: 1257-1264, 2006.
31. Castillo M, Smith JK and Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 21: 1645-1649, 2000.
32. 1H MRS in human brain at 7 T. MAGMA 22: 1-4, 2009.
33. Majos C, Alonso J, Aguilera C, et al: Proton magnetic resonance spectroscopy [(1)H MRS] of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization. Eur Radiol 13: 582-591, 2003.
34. 1H NMR spectral pattern of perchloric acid extracts of C6 cells with growth. NMR Biomed 19: 223-230, 2006.
35. De Edelenyi FS, Rubin C, Esteve F, et al: A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med 6: 1287-1289, 2000.
36. Weissleder R and Mahmood U: Molecular imaging. Radiology 219: 316-333, 2001.
37. Sakariassen P, Immervoll H and Chekenya M: Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies. Neoplasia 9: 882-892, 2007.
38. Schlemmer HP, Pichler BJ, Schmand M, et al: Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248: 1028-1035, 2008.